fda semaglutide warning warns dangers of using ‘off brand’ weight loss drugs FDA alerts health care providers,

These differences may relate to formulation-specific excipients and physicochemical properties (e.g., dispersion and carrier stability), as suggested by prior workalthough these attributes were not directly characterized in the present study [54,55]

Healthcare professionals recommend focusing on evidence-based strategies alongside Wegovy, including structured dietary changes, regular physical activity, behavioural support, and regular medical monitoring rather than adding unproven supplements

doi: 10.1136/gutjnl-2015-309990 46 MiyakeS.KimS.SudaW.OshimaK.NakamuraM.MatsuokaT.et al

Interdisciplinary Studies: Integration of endocrinology, reproductive medicine, and molecular pharmacology could illuminate interactions between incretin pathways and reproductive signaling